Aristopharma to disburse stakeholder payments through bKash
Aristopharma Limited, a leading pharmaceutical company in Bangladesh, will disburse payments directly to stakeholders via bKash as part of its drive towards cashless transactions.
The initiative aims to streamline field-level financial management, making it simpler, more transparent, and more secure. Aristopharma expects the move to support the growth of a cashless ecosystem by minimising risks associated with physical cash handling.
Aristopharma and bKash recently signed an agreement at Aristopharma's head office in the presence of senior officials from both organisations.
Keep updated, follow The Business Standard's Google news channel
Aristopharma was represented by Deputy Managing Director Mohammad Sahid Hassan, Director Ahmed Imtiaz Hassan, Executive Director and Company Secretary Md Maminul Islam, and Executive Director Mohammad Siddiqul Alam Sikder.
bKash was represented by Chief Commercial Officer Ali Ahmmed, Head of Business Sales Masrur Chowdhury, and General Manager, Business Sales Department, Md Somel Reza Khan.
Officials from both organisations expressed interest in collaborating on future initiatives to further expand cashless transactions.
Under the agreement, Aristopharma will utilise bKash's Disbursement Solution to transfer payments directly to stakeholders' bKash accounts.
